PI3 antibody (M00364) performs well in IHC, ELISA (Cap) and shows reactivity with Human.

  • Validated for inter-lot consistency, specificity, and reproducibility
  • Committed to quality since 1993
  • Over 1 Publication
Filter:
M00364 Elafin primary antibodies IHC testing 1m00364 elafin primary antibodies elisa testing 2

Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7)

PI3 antibody

Reactive SpeciesHostApplication
HumanMouseIHC, ELISA (Cap)

SKU: M00364

Size: 100 μg

Bundle to save: I do not want free secondary ab
Price:
$370/100 μg

In stock. Ships Next Business Day.

Quantity: 1

1
Get A Quote
Guarantee / Product Promise

Tested Applications

PI3 antibody was positively detected by IHC in:

human tonsil tissue

Use EDTA pH 8.0 for antigen retrieval; (*) citrate buffer pH 6.0 is an alternative.

Recommend Dilution

Application
Dilution
Species
Immunohistochemistry (Paraffin-embedded Section)
0.5-1μg/ml
ELISA (Cap)
1-5μg/ml

* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.

Reactive Data

Filter:
Boster Guarantee:What is this?
IHC
IF
Human
Tested
Recommend
Monkey
Predicted
Predicted

Product Information

Product Name
Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7)
View all PI3 Antibodies
Form
Lyophilized
Uniprot
Gene ID
Storage & Handling
Store at -20˚C for one year from date of receipt. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for six months. Avoid repeated freeze-thaw cycles.
Host
Mouse
Contents
Each vial contains 4mg Trehalose, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg NaN3.
Clonality
Monoclonal
Clone Number
C7
Isotype
Mouse IgG1
Immunogen
E. coli-derived human Elafin/Skalp recombinant protein (Position: A61-Q117).
Cross-Reactivity
No cross-reactivity with other proteins.
Reconstitution
Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Calculated Molecular Weight

12.3 kDa

Background of PI3
Elafin, also known as peptidase inhibitor 3 or skin-derived antileukoprotease (SKALP), is a protein that in humans is encoded by the PI3 gene. This gene encodes an elastase-specific inhibitor that functions as an antimicrobial peptide against Gram-positive and Gram-negative bacteria, and fungal pathogens. The protein contains a WAP-type four-disulfide core (WFDC) domain, and is thus a member of the WFDC domain family. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. And this gene belongs to the centromeric cluster. Expression of this gene is upgulated by bacterial lipopolysaccharides and cytokines.
Cite This Product
Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7) (Boster Biological Technology, Pleasanton CA, USA, Catalog # M00364)

Protocols

Immunohistochemistry (IHC) protocol for PI3 antibody

Publications

Application:
Species:
Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasis
Published: 2023-07-20
Journal: JOURNAL OF DERMATOLOGICAL SCIENCE
Application: IHC
Impact Factor: 4.60
Species: Human
PMID: 37543503

Review

Have you used Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7)?

Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.

Product Promise

We promise Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7) performs excellently in relevant applications for IHC, ELISA (Cap). If it doesn't perform as promised, we will refund the product. Learn more

In stock
Order Product
M00364
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Oct 6, 2026